Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bavituximab with Gemcitabine in Stage IV Pancreatic Cancer
NCT01272791Phase 2Completed
- Sponsor
- Avid Bioservices, Inc.
- Start
- Jan 2011
- Primary completion
- Feb 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of bavituximab in pancreatic cancer (PC), sponsored by Avid Bioservices, Inc.. Started Jan 2011; status: completed.
02
Drugs
bavituximab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01272791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272791.